filmov
tv
GDFUA
0:05:53
GDUFA II Training IR and DR Letters, Michael Folkendt
0:03:12
Part-2 GDUFA lll updates l Generic Drug User Fee Act l FDA l Regulatory Affairs l #pharmaceuticals
0:07:48
GDUFA II Training - Goals Integration, Ted Sherwood
0:17:19
GDUFA II – Review Timelines (14of27) Generic Drugs Forum 2018
0:17:29
GDUFA II User Fees: Update on Year One (21of27) Generic Drugs Forum 2018
0:23:06
GDUFA II Pre-ANDA Program Meetings: Advice for Success (10of27) Generic Drugs Forum 2018
0:31:03
ANDA Performance/Operations Update (3of27) Generic Drugs Forum April 2018
0:22:14
Keynote: Generic Drug Program Update (1of16) Generic Drugs Forum 2020
0:00:13
Anunen✨️
0:35:52
Pre-ANDA Interactions with the FDA (6of16) Generic Drugs Forum 2020
0:24:07
Filing Review Basics – Examples of Refuse-to-Receive (RTR) (15of27) Generic Drugs Forum 2018
0:13:36
Application Communications: RBPM Communication with Industry throughout the IQA (24of27) GDF 2018
0:20:14
Generic Drug Product Quality Assessment (22of27) Generic Drugs Forum 2018
0:00:13
August 26, 2024
0:20:18
Drug Substance Quality Assessment: Best Practices (23of27) Generic Drugs Forum 2018
0:00:16
Çal oynasın
0:00:08
ASMR ☔ 🌈 strawberries in chocolate VS 🍓 🍥 🍫 😋 😍 😌 🍓 🍥 🍫 #shorts
0:47:39
New Programs and Requirements Under FDARA (5of16) Generic Drugs Forum 2020
1:06:01
The Importance of Generic Drug Pharmacovigilance (9of16) Generic Drugs Forum 2020
0:45:22
Application Case Studies on FDA’s Action Letter Timing (16of16) GDF 2020
0:33:06
Keynote Address by Dr. Uhl (1of27) Generic Drugs Forum 2018
0:00:24
21 December 2024
0:12:35
Integrated Quality Assessment Process (19of27) Generic Drugs Forum 2018
Вперёд
0:05:53
0:03:12
0:07:48
0:17:19
0:17:29
0:23:06
0:31:03
0:22:14
0:00:13
0:35:52
0:24:07
0:13:36
0:20:14
0:00:13
0:20:18
0:00:16
0:00:08
0:47:39
1:06:01
0:45:22
0:33:06
0:00:24
0:12:35